Neuropsychiatric disturbances in atypical parkinsonian disorders

: Multiple system atrophy (MSA), progressive supranuclear palsy (PSP), and corticobasal degeneration (CBD) are the most common atypical parkinsonisms. These disorders are characterized by varying combinations of autonomic, cerebellar and pyramidal system, and cognitive dysfunctions. In this paper, we reviewed the evidence available on the presence and type of neuropsychiatric disturbances in MSA, PSP, and CBD. A MedLine, Excerpta Medica, PsycLit, PsycInfo, and Index Medicus search was performed to identify all articles published on this topic between 1965 and 2018. Neuropsychiatric disturbances including depression, anxiety, agitation, and behavioral abnormalities have been frequently described in these disorders, with depression as the most frequent disturbance. MSA patients show a higher frequency of depressive disorders when compared to healthy controls. An increased frequency of anxiety disorders has also been reported in some patients, and no studies have investigated apathy. PSP patients may have depression, apathy, disinhibition, and to a lesser extent, anxiety and agitation. In CBD, neuropsychiatric disorders are similar to those present in PSP. Hallucinations and delusions are rarely reported in these disorders. Neuropsychiatric symptoms in MSA, PSP, and CBD do not appear to be related to the severity of motor dysfunction and are one of the main factors that determine a low quality of life. The results suggest that neuropsychiatric disturbances should always be assessed in patients with atypical parkinsonisms.

[1]  J. Rowe,et al.  Neurotransmitter deficits from frontotemporal lobar degeneration , 2018, Brain : a journal of neurology.

[2]  A. Berardelli,et al.  Abnormal Resting-State Functional Connectivity in Progressive Supranuclear Palsy and Corticobasal Syndrome , 2017, Front. Neurol..

[3]  Murray Grossman,et al.  Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria , 2017, Movement disorders : official journal of the Movement Disorder Society.

[4]  G. Wenning,et al.  Multiple system atrophy: insights into a rare and debilitating movement disorder , 2017, Nature Reviews Neurology.

[5]  M. Zappia,et al.  Obsessive compulsive personality disorder in Progressive Supranuclear Palsy, Multiple System Atrophy and Essential Tremor. , 2016, Parkinsonism & related disorders.

[6]  A. Berardelli,et al.  MRI gray and white matter measures in progressive supranuclear palsy and corticobasal syndrome , 2016, Journal of Neurology.

[7]  E. Matsubara,et al.  Brain Perfusion in Corticobasal Syndrome with Progressive Aphasia , 2016, Dementia and Geriatric Cognitive Disorders Extra.

[8]  F. Niccolini,et al.  Cholinergic imaging in dementia spectrum disorders , 2016, European Journal of Nuclear Medicine and Molecular Imaging.

[9]  A. Berardelli,et al.  Primary motor cortex LTP/LTD-like plasticity in probable corticobasal syndrome. , 2016, Journal of neurophysiology.

[10]  J. Grafman,et al.  Neuropsychiatric effects of neurodegeneration of the medial versus lateral ventral prefrontal cortex in humans , 2015, Cortex.

[11]  Ke Chen,et al.  The Global Cognition, Frontal Lobe Dysfunction and Behavior Changes in Chinese Patients with Multiple System Atrophy , 2015, PloS one.

[12]  M. Haut,et al.  Completed suicide in a case of clinically diagnosed progressive supranuclear palsy. , 2015, Neurodegenerative disease management.

[13]  A. Strafella,et al.  Apathy in Parkinson's disease: clinical features, neural substrates, diagnosis, and treatment , 2015, The Lancet Neurology.

[14]  K. Abe,et al.  Simultaneous assessment of cognitive and affective functions in multiple system atrophy and cortical cerebellar atrophy in relation to computerized touch-panel screening tests , 2015, Journal of the Neurological Sciences.

[15]  M. Stamelou,et al.  Atypical parkinsonism: diagnosis and treatment. , 2015, Neurologic clinics.

[16]  E. Tolosa,et al.  The phenotypic spectrum of progressive supranuclear palsy: A retrospective multicenter study of 100 definite cases , 2014, Movement disorders : official journal of the Movement Disorder Society.

[17]  A. Berardelli,et al.  Psychiatric disturbances in patients with progressive supranuclear palsy: a case-control study. , 2014, Parkinsonism & related disorders.

[18]  H. Akiyama,et al.  Corticobasal degeneration initially developing motor versus non‐motor symptoms: a comparative clinicopathological study , 2014, Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society.

[19]  W. Poewe,et al.  Cognitive impairment in multiple system atrophy: A position statement by the neuropsychology task force of the MDS multiple system atrophy (MODIMSA) study group , 2014, Movement disorders : official journal of the Movement Disorder Society.

[20]  I. Litvan,et al.  Behavioral abnormalities in progressive supranuclear palsy , 2013, Psychiatry Research.

[21]  A. Berardelli,et al.  Fifty years of progressive supranuclear palsy , 2013, Journal of Neurology, Neurosurgery & Psychiatry.

[22]  M. Stamelou,et al.  Atypical parkinsonism: an update , 2013, Current opinion in neurology.

[23]  E. Tolosa,et al.  A cross-sectional multicenter study of cognitive and behavioural features in multiple system atrophy patients of the parkinsonian and cerebellar type , 2013, Journal of Neural Transmission.

[24]  Mark Hallett,et al.  Criteria for the diagnosis of corticobasal degeneration , 2013, Neurology.

[25]  A. Stefani,et al.  Sad and happy facial emotion recognition impairment in progressive supranuclear palsy in comparison with Parkinson's disease. , 2012, Parkinsonism & related disorders.

[26]  K. Bertram,et al.  Visual hallucinations in the differential diagnosis of parkinsonism , 2012, Journal of Neurology, Neurosurgery & Psychiatry.

[27]  W. Oertel,et al.  Health-Related Quality of Life in Multiple System Atrophy and Progressive Supranuclear Palsy , 2011, Neurodegenerative Diseases.

[28]  M. Hashimoto,et al.  Neuropsychiatric symptoms of progressive supranuclear palsy in a dementia clinic , 2011, Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society.

[29]  J. Hodges,et al.  Behavioural symptoms in progressive supranuclear palsy and frontotemporal dementia , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[30]  A. Lees,et al.  Does corticobasal degeneration exist? A clinicopathological re-evaluation. , 2010, Brain : a journal of neurology.

[31]  M. Jahanshahi,et al.  A comparison of depression, anxiety, and health status in patients with progressive supranuclear palsy and multiple system atrophy , 2010, Movement disorders : official journal of the Movement Disorder Society.

[32]  A. Kertesz,et al.  Behavior and cognition in corticobasal degeneration and progressive supranuclear palsy , 2010, Journal of the Neurological Sciences.

[33]  Nir Giladi,et al.  Cognition in multiple system atrophy: neuropsychological profile and interaction with mood , 2010, Journal of Neural Transmission.

[34]  C. Antke,et al.  In vivo imaging of synaptic function in the central nervous system I. Movement disorders and dementia , 2009, Behavioural Brain Research.

[35]  A. Calder,et al.  Emotion recognition in progressive supranuclear palsy , 2009, Journal of Neurology, Neurosurgery & Psychiatry.

[36]  J. Ioannidis,et al.  The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration , 2009, BMJ : British Medical Journal.

[37]  B. Borroni,et al.  Pattern of behavioral disturbances in corticobasal degeneration syndrome and progressive supranuclear palsy , 2009, International Psychogeriatrics.

[38]  P Sandroni,et al.  Second consensus statement on the diagnosis of multiple system atrophy , 2008, Neurology.

[39]  B. Borroni,et al.  Cognitive and behavioral assessment in the early stages of neurodegenerative extrapyramidal syndromes. , 2008, Archives of gerontology and geriatrics (Print).

[40]  K. Ito,et al.  Cognitive impairments in multiple system atrophy , 2008, Neurology.

[41]  G. Halliday,et al.  Excessive dopamine neuron loss in progressive supranuclear palsy , 2008, Movement disorders : official journal of the Movement Disorder Society.

[42]  J. Parisi,et al.  Mesopontine cholinergic neuron involvement in Lewy body dementia and multiple system atrophy , 2008, Neurology.

[43]  H. Amthauer,et al.  Dopamine transporters, D2 receptors, and glucose metabolism in corticobasal degeneration , 2006, Movement disorders : official journal of the Movement Disorder Society.

[44]  M. T. Pellecchia,et al.  Health‐related quality of life in multiple system atrophy , 2006, Movement disorders : official journal of the Movement Disorder Society.

[45]  D. Mash,et al.  Visual Hallucinations in Progressive Supranuclear Palsy , 2006, European Neurology.

[46]  R. Moretti,et al.  Cognitive Impairment in the Lateralized Phenotype of Corticobasal Degeneration , 2005, Dementia and Geriatric Cognitive Disorders.

[47]  A. Schrag,et al.  Depressive symptoms and life satisfaction in patients with multiple system atrophy , 2005, Movement disorders : official journal of the Movement Disorder Society.

[48]  A. Lees,et al.  Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism. , 2005, Brain : a journal of neurology.

[49]  M. Jahanshahi,et al.  Health‐related quality of life in patients with progressive supranuclear palsy , 2003, Movement disorders : official journal of the Movement Disorder Society.

[50]  E. Benarroch.  Brainstem in Multiple System Atrophy: Clinicopathological Correlations , 2003, Cellular and Molecular Neurobiology.

[51]  D. Dickson,et al.  Diagnostic accuracy of progressive supranuclear palsy in the Society for Progressive Supranuclear Palsy Brain Bank , 2003, Movement disorders : official journal of the Movement Disorder Society.

[52]  J. Parisi,et al.  Depletion of mesopontine cholinergic and sparing of raphe neurons in multiple system atrophy , 2002, Neurology.

[53]  I Litvan,et al.  Neuropsychiatric symptoms of patients with progressive supranuclear palsy and Parkinson's disease. , 2001, The Journal of neuropsychiatry and clinical neurosciences.

[54]  Y Ben-Shlomo,et al.  Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study , 1999, The Lancet.

[55]  S Tanada,et al.  Positron emission tomographic measurement of acetylcholinesterase activity reveals differential loss of ascending cholinergic systems in Parkinson's disease and progressive supranuclear palsy , 1999, Annals of neurology.

[56]  F. Girotti,et al.  Affective symptoms in multiple system atrophy and Parkinson’s disease: response to levodopa therapy , 1999, Journal of neurology, neurosurgery, and psychiatry.

[57]  R. Khurana,et al.  Occurrence of depressive symptoms in Shy-Drager syndrome , 1999, Clinical Autonomic Research.

[58]  I Litvan,et al.  Consensus statement on the diagnosis of multiple system atrophy , 1998, Journal of the Neurological Sciences.

[59]  M. Mega,et al.  Neuropsychiatric features of corticobasal degeneration , 1998, Journal of neurology, neurosurgery, and psychiatry.

[60]  I Litvan,et al.  Natural history and survival of 14 patients with corticobasal degeneration confirmed at postmortem examination , 1998, Journal of neurology, neurosurgery, and psychiatry.

[61]  Jeffrey L. Cummings,et al.  Neuropsychiatric aspects of progressive supranuclear palsy , 1996, Neurology.

[62]  J. Hodges,et al.  Neuropsychological performance, disease severity, and depression in progressive supranuclear palsy , 1996, Journal of Neurology.

[63]  M. Trimble,et al.  Depression in multiple system atrophy and in idiopathic Parkinson's disease: A pilot comparative study , 1996, Biological Psychiatry.

[64]  R. Doody,et al.  Neuropsychological functioning in cortical-basal ganglionic degeneration , 1996, Neurology.

[65]  L. Golbe,et al.  Psychiatric symptoms in progressive supranuclear palsy. , 1995, Psychosomatics.

[66]  P. Lantos,et al.  Accumulation of tubular structures in oligodendroglial and neuronal cells as the basic alteration in multiple system atrophy , 1992, Journal of the Neurological Sciences.

[67]  A. Lees,et al.  The clinical features and natural history of the Steele‐Richardson‐Olszewski syndrome (progressive supranuclear palsy) , 1986, Neurology.

[68]  E. Hirsch,et al.  Dopaminergic and cholinergic lesions in progressive supranuclear palsy , 1985, Annals of neurology.

[69]  J. Hodges,et al.  Explorer Validation of the new consensus criteria for the diagnosis of corticobasal degeneration , 2016 .

[70]  R. Petersen,et al.  Neuropsychiatric features in 36 pathologically confirmed cases of corticobasal degeneration. , 2007, The Journal of neuropsychiatry and clinical neurosciences.

[71]  M. Albert,et al.  Corticobasal degeneration: neuropsychological and clinical correlates. , 1997, The Journal of neuropsychiatry and clinical neurosciences.

[72]  K. Shannak,et al.  Brain monoamines in progressive supranuclear palsy--comparison with idiopathic Parkinson's disease. , 1994, Journal of neural transmission. Supplementum.